FDA Webinar: Postmarketing Drug Safety Compliance: 2019 Inspection Findings
FDA’s Postmarketing Adverse Drug Experience (PADE) Compliance Program monitors industry compliance with postmarketing laws and regulations for products regulated by the Center for Drug Evaluation...